Welcome to medications.com

ADRs in Focus: Novartis ADRs Decline - Houston Chronicle

Scotcher said generic versions of osteoporosis drug Zometa and bone disease drug Aclasta could go on sale as soon as 2011, and its hypertension drug Diovan ...

http://www.chron.com/disp/story.m... | Posted: Fri Feb 29 16:57:48 -0500 2008




ADVERTISEMENT
© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com